Abstract
Erectile dysfunction (ED) is often not considered in the same context as such traditional cardiovascular conditions as hypertension, dyslipidemia, diabetes, or ischemic heart disease. The detection of ED might be one of the most powerful tools to help manage cardiovascular disease in men. Clinical research suggests that the penile vascular bed is a sensitive indicator of early systemic endothelial cell or smooth muscle dysfunction. ED could be one of the initial signs of oxidative stress that occurs before the development of the structural, occlusive cardiovascular disease. ED is becoming a barometer of overall global cardiovascular risk and should be viewed in this context rather than as “just a problem with the penis.” Asking men about ED as part of the review of systems is an effective means of practicing preventive vascular medicine.
Similar content being viewed by others
References and Recommended Reading
Murray CJL, Lopez AD: The Global Burden of Disease and Injury Series, Volume 1: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Cambridge, MA: Harvard University Press; 1996.
NIH Consensus Development Panel on Impotence. NIH Consensus Conference: Impotence. JAMA 1993, 270:83–90.
Derby CA, Mohr BA, Goldstein I, et al.: Modifiable risk factors and erectile dysfunction: Can lifestyle changes modify risk? Urology 2000, 56:302–306.
Maas R, Schwedhelm E, Albsmeier J, Boger RH: The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function. Vasc Med 2002, 7:213–225.
Feldt-Rasmussen B: Microalbuminuria, endothelial dysfunction and cardiovascular risk. Diabetes Metab 2000, 26(Suppl 4):64–66.
Jeremy JY, Angelini GD, Khan M, et al.: Platelets, oxidant stress and erectile dysfunction: an hypothesis. Cardiovasc Res 2000, 46:50–54.
Jones RWA, Rees RW, Minhas S, et al.: Oxygen free radicals and the penis. Expert Opin Pharmacother 2002, 3:889–897.
Solomon H, Man JW, Jackson G: Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart 2003, 89:251–253.
Lue TF: Erectile dysfunction. N Engl J Med 2000, 342:1802–1813.
Feldman HA, Goldstein I, Hatzichristou DG, et al.: Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994, 151:54–61.
Laumann EO, Paik A, Rosen RC: Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999, 281:537–544.
Virag R, Bouilly P, Frydman D: Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet 1985, 1:181–184.
Jackson G: Erectile dysfunction and cardiovascular disease. Int J Clin Pract 1999, 53:363–368.
Sullivan ME, Keoghane SR, Miller MA: Vascular risk factors and erectile dysfunction. BJU Int 2001, 87:838–845.
Bacon CG, Hu FB, Biovannucci E, et al.: Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. Diabetes Care 2002, 25:1458–1463.
Moulik PK, Hardy KJ: Hypertension, anti-hypertensive drug therapy and erectile dysfunction in diabetes. Diabet Med 2003, 20:290–293.
Jensen J, Lendorf A, Stimpel H, et al.: The prevalence and etiology of impotence in 101 male hypertensive outpatients. Am J Hypertens 1999, 12:271–275.
Wei M, Macera CA, Davis DR, et al.: Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction. Am J Epidemiol 1994, 140:930–937.
Bacon CG, Mittleman MA, Kawachi I, et al.: Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med 2003, 139:161–168.
Kirby M, Jackson G, Betteridge J, Friedli K: Is erectile dysfunction a marker for cardiovascular disease? Int J Clin Pract 2001, 55:614–618.
Rehman J, Melman A: Normal anatomy and physiology. In Male Sexual Function. A Guide to Clinical Management. Edited by Mulcahy JJ. Totowa, NJ: Humana Press; 2001:1–46.
Sullivan ME, Thompson CS, Dashwood MR, et al.: Nitric oxide and penile erection: Is erectile dysfunction another manifestation of vascular disease? Cardiovasc Res 1999, 43:658–665.
Kaiser DR, Billups K, Mason C, et al.: Impaired brachial artery endothelium-dependent and-independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol 2004, 43:179–184. This paper compares men with ED and no known risk factors for cardiovascular disease with normal control subjects without ED using brachial artery endothelial function testing. The ED group was found to have evidence for abnormal endothelial-dependent and-independent function despite the absence of the usual risk factors for atherosclerosis. The presence of ED should alert physicians to the possible presence or future development of vascular disease.
Bocchio M, Desideri G, Scarpelli P, et al.: Endothelial cell activation in men with erectile dysfunction without cardiovascular risk factors and overt vascular damage. J Urol 2004, 171:1601–1604. This study used biochemical markers of endothelial cell activation to examine men with ED and no clinical risk factors for cardiovascular disease and normal control subjects without ED. The finding that men with ED and no risk factors have significantly elevated markers for endothelial cell activation compared with normal controls supports the concept that ED should prompt physicians to search aggressively for vascular disease even in men who appear benign.
Gazzaruso C, Giordanetti S, De Amici E, et al.: Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation 2004, 110:22–26. This paper shows that ED is the best predictor of silent myocardial ischemia in men with uncomplicated type 2 diabetes. Based on these data, clinicians should consider ED as a risk factor for vascular disease in these men and consider more aggressive screening for coronary artery disease.
Guay AT, Perez JB, Heatley GF: Cessation of smoking rapidly decreases erectile dysfunction. Endocr Pract 1998, 4:23–26.
Guay AT, Perez JB, Jacobson J, Newton RA: Efficacy and safety of sildenafil citrate for treatment of erectile dysfunction in a population with associated organic risk factors. J Androl 2001, 22:793–797.
Esposito K, Giugliano F, Palo C, et al.: Effect of lifestyle changes on erectile dysfunction in obese men. JAMA 2004, 291:2978–2984.
Saltzman E, Guay A, Jacobson J: Improvement in erectile function in men with organic erectile dysfunction by correction of elevated cholesterol levels: a clinical observation. J Urol 2004, 172:255–258.
Billups K, Bank A, Padma-Nathan H, et al.: Erectile dysfunction is a marker for cardiovascular disease: results of the Minority Health Institute Expert Advisory Panel. J Sex Med, in press.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Billups, K.L. Endothelial dysfunction as a common link between erectile dysfunction and cardiovascular disease. Curr sex health rep 1, 137–141 (2004). https://doi.org/10.1007/s11930-004-0032-1
Issue Date:
DOI: https://doi.org/10.1007/s11930-004-0032-1